Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼±ÅÃÀû ´ëÀåÀýÁ¦¼ú ÈÄ ¿¹¹æÀû Ç×»ýÁ¦ Åõ¿©±â°£¿¡ ´ëÇÑ ÀüÇâÀû ´Ù±â°ü ¹«ÀÛÀ§ ´ëÁ¶ ¿¬±¸: 3ÀÏ ¿ä¹ý°ú 5ÀÏ ¿ä¹ý A Prospective, Multicenter, Randomized Trial for Duration of the Prophylactic Antibiotics after Elective Colorectal Surgery: 3 Days versus 5 Days

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2010³â 26±Ç 2È£ p.123 ~ 128
¹ÚÁö¿ø, ÀüÈ£°æ, ÀÌ¿ì¿ë, À±Çضõ, ¼Õ½Â±¹, ÃÖÈ¿¼º, ÀÌ°­¿µ, ¿ÀÀçȯ, À¯»ó¹ü, ÃÖ¿µÁÖ, ¹Ú¼ÒÈñ, ±èÁ¤¸¸,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁö¿ø ( Park Ji-Won ) 
±¹¸³¾Ï¼¾ÅÍ ´ëÀå¾Ï¼¾ÅÍ

ÀüÈ£°æ ( Chun Ho-Kyung ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç
ÀÌ¿ì¿ë ( Lee Woo-Yong ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç
À±Çضõ ( Yun Hae-Ran ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç
¼Õ½Â±¹ ( Sohn Seung-Kook ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖÈ¿¼º ( Choi Hyo-Seong ) 
±¹¸³¾Ï¼¾ÅÍ ´ëÀå¾Ï¼¾ÅÍ
ÀÌ°­¿µ ( Rhee Kang-Young ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¿ÀÀçȯ ( Oh Jae-Hwan ) 
±¹¸³¾Ï¼¾ÅÍ ´ëÀå¾Ï¼¾ÅÍ
À¯»ó¹ü ( Yoo Sang-Bum ) 
±¹¸³¾Ï¼¾ÅÍ ´ëÀå¾Ï¼¾ÅÍ
ÃÖ¿µÁÖ ( Choi Young-Ju ) 
±¹¸³¾Ï¼¾ÅÍ °¨¿°Å¬¸®´Ð
¹Ú¼ÒÈñ ( Park So-Hee ) 
±¹¸³¾Ï¼¾ÅÍ ¾ÏÅë°è¿¬±¸°ú
±èÁ¤¸¸ ( Kim Jung-Man ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: The use of prophylactic antibiotics in elective colorectal surgery is essential. Although postoperative prophylactic antibiotics are recommended within 24 hr, the optimal duration of the use of prophylactic antibiotics after colorectal surgery has not yet been fully proven in Korea. The aim of this study was to compare infectious outcomes in elective colorectal cancer surgery between postoperative 3-day antibiotic therapy and 5-day therapy.

Methods: We conducted a multicenter, randomized trial of a 3-day use vs. a 5-day use of the second-generation cephalosporin cefotetan after elective colorectal surgery. The main outcome measures were the incidences of surgical site infection and all other infectious complications within 21 days after surgery.

Results: A total of 306 patients were enrolled. Fifty-one patients were excluded because they received additional surgery or dropped out during the study. Two-hundred fifty-five patients were analyzed in this study. The two groups were similar in terms of demographics, ASA score, tumor location, tumor stage, surgical approach (conventional open vs. laparoscopy-assisted vs. robotic-assisted), and type of operation. The incidences of surgical site infection were not significantly different between the 3-day use group (4/130 or 3.1%) and the 5-day use group (3/125 or 2.4%) (P=1.000). Incidences of overall infectious diseases did not differ significantly between the two groups. Postoperatively, both groups had similar values in their white blood cell count, absolute neutrophil count, and C-reactive protein levels. However, the number of patients is small to draw a definite conclusion in this study.

Conclusion: Three-day cefotetan administration may be not inferior in preventing surgical site infection compared to 5-day antibiotic administration. However, further studies with a large number of patients are needed before a definite conclusion can be drawn.

Å°¿öµå

¿¹¹æÀû Ç×»ýÁ¦;´ëÀå ¼ö¼ú
Antibiotics prophylaxis;Colorectal surgery

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS